Home / OBI.L : LSE

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does OBI.L make money? Does OBI.L have pricing power? What's the Earnings Whisper? Will OBI.L profit more as the business scales? What is OBI.L's management track record? Is OBI.L's current price justified?

Ondine Biomedical Inc.

10.85p +$2.10 (+23.98%)

LSE · 16 Sep 2026 08:46 UTC

Previous Close

10.75p

Day Range

10.5p10.85p

Year Range

7.5p16p

Market Cap

56.23M

AVG Volume

504.96K

Trailing/Forward PE

-3.18/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-09-29

Primary Exchange

London Stock Exchange

Revenue (CAD)

OBI.L Revenue (CAD) by quarter
Period	Revenue (CAD)
25 Q4	1.62M
25 Q2	1.04M
24 Q4	1.2M
24 Q2	865.23K
23 Q4	766.82K
23 Q2	431.85K
22 Q4	395.74K
22 Q2	248.16K
21 Q4	593.65K
21 Q2	1.95M

Net Income (CAD)

OBI.L Net Income (CAD) by quarter
Period	Net Income (CAD)
25 Q4	-16.87M
25 Q2	-12.9M
24 Q4	-11.44M
24 Q2	-7.82M
23 Q4	-6.44M
23 Q2	-7.97M
22 Q4	-11.37M
22 Q2	-8.12M
21 Q4	-45.46M
21 Q2	-4.54M

Operating Income (CAD)

OBI.L Operating Income (CAD) by quarter
Period	Operating Income (CAD)
25 Q4	-17.36M
25 Q2	-12.86M
24 Q4	-11.72M
24 Q2	-7.89M
23 Q4	-6.7M
23 Q2	-8.1M
22 Q4	-12.3M
22 Q2	-7.96M
21 Q4	-12.95M
21 Q2	-4.5M

EBITDA (CAD)

OBI.L EBITDA (CAD) by quarter
Period	EBITDA (CAD)
25 Q4	-17.08M
25 Q2	-12.54M
24 Q4	-11.13M
24 Q2	-4.22M
23 Q4	-6.42M
23 Q2	-7.79M
22 Q4	-12.04M
22 Q2	-7.74M
21 Q4	-12.78M
21 Q2	-4.17M

Cash Flows (CAD)

OBI.L Cash Flows (CAD) by quarter
Period	Cash Flows (CAD)
25 Q4	-13.53M
25 Q2	-10.48M
24 Q4	-8.23M
24 Q2	-7.15M
23 Q4	-5.27M
23 Q2	-8.42M
22 Q4	-8.88M
22 Q2	-8.23M
21 Q4	-10.63M
21 Q2	-1.97M

EPS (CAD)

OBI.L EPS (CAD) by quarter
Period	EPS (CAD)
25 Q4	-0.03
25 Q2	-0.03
24 Q4	-0.04
24 Q2	-0.02
23 Q4	-0.03
23 Q2	-0.04
22 Q4	-0.06
22 Q2	-0.04
21 Q4	-0.24
21 Q2	-0.02

Expenses (CAD)

OBI.L Expenses (CAD) by quarter
Period	Expenses (CAD)
25 Q4	18.16M
25 Q2	13.27M
24 Q4	12.25M
24 Q2	8.16M
23 Q4	6.88M
23 Q2	8.23M
22 Q4	10.86M
22 Q2	8.14M
21 Q4	13.07M
21 Q2	5.25M

Cash & Debt (CAD)

OBI.L Cash & Debt (CAD) by quarter
Period	Cash & Debt (CAD)
25 Q4	10.58M
25 Q2	5.59M
24 Q4	9.77M
24 Q2	1.22M
23 Q4	2.98M
23 Q2	4.44M
22 Q4	13.12M
22 Q2	20.93M
21 Q4	30.36M
21 Q2	575K

Debt ratios

OBI.L Debt ratios by quarter
Period	Debt ratios
25 Q4	0.23
25 Q2	0.15
24 Q4	0.32
24 Q2	0.03
23 Q4	0.07
23 Q2	0.09
22 Q4	0.33
22 Q2	0.61
21 Q4	0.94
21 Q2	-1.65

Margins

OBI.L Margins by quarter
Period	Margins
25 Q4	43.78%
25 Q2	37.02%
24 Q4	44.45%
24 Q2	29.92%
23 Q4	22.71%
23 Q2	-10.05%
22 Q4	-25%
22 Q2	-30.15%
21 Q4	17.85%
21 Q2	34.94%

Return on Capital

OBI.L Return on Capital by quarter
Period	Return on Capital
25 Q4	-483.46%
25 Q2	-1770.21%
24 Q4	-166.35%
24 Q2	-41147.37%
23 Q4	-309.02%
23 Q2	-192.3%
22 Q4	-97.64%
22 Q2	-37.2%
21 Q4	-153.28%
21 Q2	12.36%

Shares Outstanding

OBI.L Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	488.09M
25 Q2	437.24M
24 Q4	303.07M
24 Q2	241.47M
23 Q4	200.1M
23 Q2	194.72M
22 Q4	194.59M
22 Q2	194.59M
21 Q4	194.58M
21 Q2	194.58M

Book Value Per Share (CAD)

OBI.L Book Value Per Share (CAD) by quarter
Period	Book Value Per Share (CAD)
25 Q4	0.01
25 Q2	0
24 Q4	0.02
24 Q2	0
23 Q4	0.01
23 Q2	0.02
22 Q4	0.06
22 Q2	0.11
21 Q4	0.15
21 Q2	-0.19

Total Assets (CAD)

OBI.L Total Assets (CAD) by quarter
Period	Total Assets (CAD)
25 Q4	14.4M
25 Q2	8.79M
24 Q4	12.82M
24 Q2	4.03M
23 Q4	5.73M
23 Q2	7.41M
22 Q4	16.57M
22 Q2	25.31M
21 Q4	34.14M
21 Q2	2.55M

No video analysis for this stock yet. Request one from our team.

AI Analysis

Ondine Biomedical Inc.

Video analysis: OBI.L

Similar companies